Twenty-one years after it bought over a company producing pharmaceutical tubing in Jambusar district in Gujarat state, SCHOTT AG has earmarked the plant as a production hub not just for the country, but for SCHOTT pharma tubing in Asia.
The plant is an ideal example of Prime Minister Modi's campaign to “Make in India, for the world.” According to Georg Sparschuh, MD, SCHOTT Glass India, the Jambusar plant had reached up to 40 per cent export rate, in addition to the rapidly growing domestic demand. While domestic demands have been their main focus, the increased capacity with two new tanks is expected to cater to the exports, which may even cross 40 per cent.
Solely owned by the Carl Zeiss Foundation, the parent company SCHOTT AG is present across many sectors besides pharma and life sciences, including home appliances, electronics, optics, automotive and aviation industries. The company has production sites and sales offices in 34 countries.
In fiscal year 2017/2018 (October 1, 2017, to September 30, 2018), Mainz, Germany headquartered company clocked global sales of Euro 2.08 billion in 34 countries, with Europe's share the highest (46 per cent, Euro 963 million; 9,450 employees).
The Asia and South Pacific region made up 25 per cent of sales (Euro 517 million; 2,800 employees) with North America in the third place, with 23 per cent sales (Euro 475 million; 2,050 employees). The annual report does not provide a break out of sales per segment, but Dr. Patrick Markschläger, Executive VP, SCHOTT AG, Business Unit Tubing indicated that pharmaceuticals - Pharmaceutical Tubing and Packaging - is the biggest business for SCHOTT Glass.
This story is from the December 16-31, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 16-31, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation